Skip to content

: CD19 and CD58 Cell Surface Marker Evaluation, Body Fluid

Published: August 9, 2026Updated: August 16, 2026

: This test uses flow cytometry to identify and count cells in a body fluid sample that carry the CD19 and CD58 surface markers. It is used to help characterize certain immune and blood cell populations.

Quick summary

[": It measures CD19- and CD58-positive cells in a body fluid to support evaluation of immune or blood cell disorders."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
51355-6
Short code
CD19CD58BF
Synonyms
CD19+CD58+ Cells NFr Fld
Category
chemistry
Sample
serum
Container
Sterile, anticoagulated collection tube (e.g., sodium heparin or EDTA tube) appropriate for flow cytometry. For cerebrospinal fluid, a sterile polypropylene tube is preferred. Containers should be labeled with patient identifiers, specimen source, and collection time.
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
Flow cytometry using fluorescently labeled monoclonal antibodies against CD19 and CD58 surface markers, with subsequent enumeration of positive cells as a percentage of total lymphocytes or absolute count per unit volume.
CPT
88184
SNOMED
395124004
Specimen volume
Minimum 1 mL of body fluid is generally required, though larger volumes (e.g., 3-5 mL of CSF) improve cell yield and detection sensitivity for rare populations. Volume requirements may vary based on cell concentration and clinical priority.
Stability
Specimens should be processed as soon as possible, ideally within 4 hours of collection when maintained at room temperature (18-25°C). Refrigeration (2-8°C) may be acceptable for up to 24 hours for some fluid types, but viability and antigen expression may decline with prolonged storage.
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–48 hours
Order
routine

: What This Test Measures

: The test detects cells expressing CD19, a marker found mainly on B lymphocytes, and CD58, a surface protein present on many immune and other cells. Flow cytometry is used to sort and count cells carrying these markers in the fluid sample provided.

: Why It May Be Ordered

: Your clinician may order this test to investigate an abnormal cell population, evaluate a suspected lymphoma or other blood/immune condition, or monitor a known disorder involving B cells or other CD58-expressing cells. It is often part of a broader panel of marker studies.

: How the Sample Is Collected

: A sample of body fluid (such as pleural, peritoneal, or cerebrospinal fluid) is collected by your healthcare provider using standard sterile technique. The sample is then sent to the laboratory for flow cytometric analysis.

: What the Results Mean

: Results describe the presence and proportion of CD19- and CD58-positive cells. Your provider interprets these findings together with your symptoms, other lab tests, and imaging. Atypical patterns may prompt additional testing; normal patterns help rule out certain conditions.

Reference range

Reference ranges are laboratory-specific and should be interpreted in conjunction with clinical findings. In healthy individuals, CD19+CD58+ cells are typically present in low proportions within peripheral blood and body fluids. Results should be compared against validated laboratory reference intervals or published literature for the specific body fluid analyzed.N/A

Specimen: serum

No special patient preparation is required. However, relevant clinical history, including suspected diagnosis, prior treatments (such as chemotherapy or immunotherapy), and information about specimen source, should be provided to the laboratory to ensure appropriate interpretation and gating strategies during flow cytometric analysis.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

: CD19 and CD58 marker analysis can help distinguish between reactive and neoplastic cell populations and support diagnosis or monitoring of B-cell and other immune-related disorders. Results should always be interpreted in the context of the full clinical picture and other laboratory findings.

Short name

: CD19/CD58 Flow Cytometry

Frequently asked questions

: Does this test diagnose cancer on its own?
: No. It provides information about cell populations that your provider uses along with other tests, imaging, and clinical findings to reach a diagnosis.
: Is the procedure painful?
: Collecting a body fluid sample may cause brief discomfort, but it is generally well tolerated and performed using standard sterile technique.
: Do I need to fast before this test?
: Fasting is usually not required for flow cytometry marker studies, but follow any specific instructions from your healthcare provider.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy